Immatics N.V. (IMTX)
NASDAQ
IMTX price, last 12 months
Key stats
- Previous close
- $5.95
- Open
- $5.86
- Day range
- $5.72 – $5.95
- 52-week range
- $5.72 – $12.41
- Volume
- 746.7K
- Avg volume (20 days)
- 1.2M
- Market cap
- $973.0M
Performance
Technicals and fundamentals
About Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
- Listed on
- NASDAQ
- Market cap
- $973.0M